|
Dr. Jane Hsiao served as the vice chairman-technical affairs of IVAX from 1995 to January 2006, when Teva acquired IVAX.
Dr. Hsiao served as IVAX�s chief technical officer (CTO) since 1996, and as chairman, CEO, and president of IVAX Animal Health, IVAX�s veterinary products subsidiary, since 1998.
From 1992 until 1995, Dr. Hsiao served as IVAX�s chief regulatory officer and assistant to the chairman. Dr. Hsiao served as chairman and president of DVM Pharmaceuticals from 1998 through 2006.
Dr. Hsiao is a director of Protalix BioTherapeutics, Inc., (PLX-AMEX) a biotech pharmaceutical company; a director of Opko Health, Inc (EXEG.OB-OTC.BB), a biotech pharmaceutical company; and Cellular Technical Services Company, Inc., a provider of products and services for the telecommunications industry. | 